Aspirin versus placebo on estrogen levels in postmenopausal women: a double-blind randomized controlled clinical trial

Aspirin versus placebo on estrogen levels in postmenopausal women: a double-blind randomized controlled clinical trial

Abstract Background Estrogen is involved in the pathogenesis of breast and gynecological cancers. Regular use of aspirin reduces estrogen levels. The present study aimed to evaluate the effect of aspirin on estrogen levels in postmenopausal women. Methods This double-blind, placebo-controlled parall...

Full description

Bibliographic Details
Main Authors: Mohammad Bagher Oghazian, Nooshin Shirzad, Mahdi Ahadi, Shalaleh Eivazi Adli, Samaneh Mollazadeh, Mania Radfar
Format: Article
Language:English
Published: BMC 2022-05-01
Series:BMC Pharmacology and Toxicology
Subjects:
Estradiol
Non-steroidal anti-inflammatory agents
Postmenopause
Sex hormone-binding globulin
Testosterone
Online Access:https://doi.org/10.1186/s40360-022-00571-9

Internet

https://doi.org/10.1186/s40360-022-00571-9

Similar Items